Brock Holst is a clinical research and quality professional with a strong foundation in pharmacy and more than two decades of experience in clinical trial operations and project leadership. He has conducted multiple audits for QualRS across the U.S. Midwest, supporting inspection readiness and GCP compliance.

Brock began his career as a hospital clinical pharmacist in the Chicago area before transitioning to Astellas Pharma (formerly Fujisawa USA), where he progressed from CRA to Clinical Project Manager and supported an NDA approval. He later served as a Senior Global Project Manager with a multinational CRO, led project management teams within electronic data capture (EDC/ePRO) organizations, and worked at Eli Lilly as a Senior Global Clinical Project Manager managing global trials and contributing to an early all-electronic clinical trial pilot.

He holds an MBA with a focus on Project Management and brings working knowledge of U.S. CFR requirements and ICH GCP standards, with practical experience across traditional and technology-enabled clinical trial environments.